{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:lymphatic:secondary-lymphedema",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-08T20:44:00.000Z",
    "updated": "2026-01-08T20:44:00.000Z",
    "contributors": [
      "copilot-agent"
    ],
    "confidence": 0.91,
    "status": "enhanced",
    "review_status": "pending_review",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high",
    "topic_id": "LYMPH-007"
  },
  "content": {
    "title": "Secondary Lymphedema Causes",
    "definition": {
      "primary": "Lymphedema resulting from damage to or obstruction of a previously normal lymphatic system, most commonly due to cancer treatment (surgery, radiation), infection, trauma, or chronic venous disease in developed countries.",
      "key_concepts": [
        "Far more common than primary lymphedema (90% of cases globally)",
        "Cancer treatment is leading cause in developed nations",
        "Filariasis is leading cause worldwide (especially tropics)",
        "May develop immediately or years after inciting event"
      ]
    },
    "epidemiology": {
      "prevalence": {
        "global": "Estimated 200 million people affected worldwide",
        "developed_countries": "Cancer-related lymphedema most common",
        "developing_countries": "Filariasis-related lymphedema predominates (120 million affected)"
      },
      "incidence_by_cancer_type": [
        {
          "cancer": "Breast cancer (post-axillary dissection)",
          "incidence": "20-40% with full axillary dissection, 5-10% with sentinel node biopsy"
        },
        {
          "cancer": "Melanoma (post-lymphadenectomy)",
          "incidence": "10-20%"
        },
        {
          "cancer": "Gynecologic cancers",
          "incidence": "15-30%"
        },
        {
          "cancer": "Prostate cancer",
          "incidence": "5-20%"
        },
        {
          "cancer": "Head and neck cancers",
          "incidence": "10-40% (facial/cervical lymphedema)"
        }
      ]
    },
    "etiology": {
      "cancer_related": {
        "surgery": {
          "mechanism": "Removal of lymph nodes disrupts drainage pathways",
          "examples": "Axillary dissection, inguinal lymphadenectomy, radical hysterectomy",
          "risk_factors": [
            "Number of lymph nodes removed",
            "Extent of dissection",
            "Prior radiation",
            "Obesity",
            "Postoperative wound complications"
          ]
        },
        "radiation": {
          "mechanism": "Fibrosis of lymphatics and lymph nodes",
          "latency": "May develop months to years after treatment",
          "synergy": "Risk dramatically increased when combined with surgery"
        },
        "tumor_obstruction": {
          "mechanism": "Direct tumor compression or infiltration of lymphatics",
          "examples": "Lymphoma, metastatic adenocarcinoma"
        }
      },
      "infectious": {
        "filariasis": {
          "mechanism": "Wuchereria bancrofti, Brugia malayi parasites lodge in lymphatics causing inflammation and fibrosis",
          "distribution": "Endemic in tropical Africa, Asia, Pacific Islands",
          "progression": "Repeated infections lead to progressive lymphedema (elephantiasis)"
        },
        "recurrent_cellulitis": {
          "mechanism": "Bacterial infection damages lymphatic vessels",
          "cycle": "Lymphedema predisposes to cellulitis, cellulitis worsens lymphedema",
          "organisms": "Streptococcus, Staphylococcus species"
        },
        "tuberculosis": {
          "mechanism": "Granulomatous lymphadenitis obstructs lymph drainage",
          "distribution": "Endemic areas"
        }
      },
      "trauma": {
        "accidental": "Severe crush injury, burns affecting lymphatics",
        "surgical": "Non-oncologic surgery disrupting lymphatics",
        "iatrogenic": "Vein harvesting for bypass (CABG), liposuction"
      },
      "inflammatory": {
        "chronic_venous_disease": {
          "mechanism": "Persistent venous hypertension overloads lymphatic system",
          "progression": "Phlebolymphedema - combined venous and lymphatic insufficiency"
        },
        "rheumatologic": "Rheumatoid arthritis, psoriatic arthritis can damage lymphatics",
        "podoconiosis": "Non-filarial endemic elephantiasis from prolonged barefoot exposure to volcanic soil"
      }
    },
    "pathophysiology": {
      "mechanism": {
        "initial_phase": "Lymphatic obstruction leads to accumulation of protein-rich interstitial fluid",
        "inflammatory_response": "Chronic protein accumulation triggers inflammation",
        "tissue_changes": "Adipose deposition, fibrosis, and irreversible tissue changes",
        "skin_changes": "Thickening, hyperkeratosis, papillomatosis in advanced disease"
      },
      "progression": "Without treatment, advances through reversible edema to irreversible fibrotic changes"
    },
    "clinical_presentation": {
      "early_stage": [
        "Soft pitting edema",
        "Resolves with elevation overnight",
        "May wax and wane"
      ],
      "intermediate_stage": [
        "Non-pitting edema",
        "Minimal reduction with elevation",
        "Skin changes beginning (thickening)"
      ],
      "late_stage": [
        "Fibrotic, non-pitting edema",
        "Skin changes: papillomatosis, hyperkeratosis",
        "Recurrent infections",
        "Functional impairment"
      ],
      "complications": [
        "Recurrent cellulitis/erysipelas",
        "Lymphangiosarcoma (Stewart-Treves syndrome) - rare but devastating",
        "Psychosocial impact",
        "Functional disability"
      ]
    },
    "staging": {
      "isl_staging": {
        "stage_0": "Subclinical - lymphatic damage present but no visible swelling",
        "stage_1": "Soft pitting edema, reversible with elevation",
        "stage_2": "Non-pitting edema, fibrotic changes, does not resolve with elevation",
        "stage_3": "Lymphostatic elephantiasis - severe volume, skin changes, disability"
      }
    },
    "prevention": {
      "cancer_treatment": [
        {
          "strategy": "Sentinel lymph node biopsy",
          "rationale": "Minimizes lymph node removal while maintaining staging accuracy"
        },
        {
          "strategy": "Axillary reverse mapping",
          "rationale": "Identifies and preserves arm-draining lymphatics during axillary dissection"
        },
        {
          "strategy": "Lymphatic-venous anastomosis at time of dissection",
          "rationale": "Prophylactic LYMPHA procedure reduces lymphedema risk"
        }
      ],
      "patient_education": [
        "Avoid blood pressure cuffs, IV access, blood draws in at-risk limb",
        "Skin care to prevent infection",
        "Early reporting of swelling",
        "Weight management",
        "Avoid constrictive clothing/jewelry"
      ]
    },
    "management": {
      "conservative": {
        "complete_decongestive_therapy": {
          "components": [
            "Manual lymphatic drainage",
            "Compression bandaging (multi-layer)",
            "Exercise",
            "Skin care",
            "Compression garments for maintenance"
          ],
          "phases": [
            "Intensive phase: Daily treatment for weeks to achieve maximum reduction",
            "Maintenance phase: Self-management with compression and exercise"
          ]
        }
      },
      "surgical": {
        "physiologic": [
          {
            "procedure": "Lymphovenous anastomosis (LVA)",
            "principle": "Connect lymphatic vessels to venules to restore drainage",
            "best_for": "Early-stage disease with functional lymphatics"
          },
          {
            "procedure": "Vascularized lymph node transfer (VLNT)",
            "principle": "Transfer lymph nodes with blood supply to affected area",
            "best_for": "Moderate disease, may reverse fibrosis"
          }
        ],
        "ablative": [
          {
            "procedure": "Suction-assisted lipectomy",
            "principle": "Remove adipose tissue that accumulates in chronic lymphedema",
            "best_for": "Non-pitting lymphedema with adipose predominance"
          },
          {
            "procedure": "Charles procedure",
            "principle": "Excision of affected tissue with skin grafting",
            "best_for": "Severe elephantiasis (rarely performed)"
          }
        ]
      }
    },
    "statement": "Secondary Lymphedema Causes is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Secondary Lymphedema Causes helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Secondary Lymphedema Causes include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Secondary Lymphedema Causes."
    }
  },
  "relationships": {
    "requires": [
      "vascular:lymphatic:anatomy",
      "vascular:diagnostics:lymphoscintigraphy"
    ],
    "enables": [
      "vascular:procedures:lva",
      "vascular:procedures:vlnt"
    ],
    "related_to": [
      "vascular:lymphatic:primary-lymphedema",
      "vascular:venous:phlebolymphedema"
    ]
  },
  "educational": {
    "learning_objectives": [
      "Identify the major causes of secondary lymphedema",
      "Understand the pathophysiology of lymphatic obstruction",
      "Apply ISL staging to classify disease severity",
      "Describe prevention strategies in cancer treatment",
      "Select appropriate conservative and surgical management"
    ],
    "key_points": [
      "Cancer treatment is the leading cause in developed countries",
      "Filariasis causes 120 million cases globally",
      "Sentinel node biopsy has dramatically reduced breast cancer-related lymphedema",
      "Complete decongestive therapy is cornerstone of management",
      "Surgical options include physiologic (restore drainage) and ablative (reduce volume) approaches"
    ],
    "clinical_pearls": [
      "Always ask about prior surgery, radiation, infections in lymphedema evaluation",
      "Bilateral lower extremity lymphedema suggests systemic cause or proximal obstruction",
      "Early intervention prevents progression to irreversible fibrotic stage",
      "Cellulitis in lymphedema requires aggressive treatment and prophylaxis"
    ]
  },
  "references": {
    "evidence_basis": "Clinical practice guidelines, systematic reviews",
    "key_guidelines": [
      {
        "organization": "International Society of Lymphology",
        "topic": "Consensus on diagnosis and treatment of lymphedema",
        "year": 2020
      }
    ],
    "terminology": {
      "snomed_ct": "234097001",
      "icd10": "I89.0"
    }
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Secondary Lymphedema Causes. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}